Pharmacological modulation of (PI3K–AKT–GSK3-β) pathway improves the hippocampus-dependent memory impairment in STZ-lesioned rodents and in transgenic AD animal models undergoing tau pathology [46,103]. The gene discussed is MAPT; the disease is Alzheimer disease.